Genstar Capital portfolio firm Tecomet has completed the acquisition of Symmetry Medical’s original equipment manufacturing (OEM) solutions business for $450m.

Symmetry’s OEM solutions business produces surgical instruments, orthopaedic implants, as well as plastic and metal sterilisation cases and trays.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

With more than 450 customers and 2,300 employees, OEM Solutions operates 13 facilities in the UK, US, Ireland, France and Malaysia.

Tecomet CEO Bill Dow said: "With this acquisition, Tecomet adds to an already wide array of services and creates a footprint that would take decades to build organically.

"We will continue to be dedicated to providing our customers the best service at the highest level of quality at competitive prices."

See Also:

"With more than 450 customers and 2,300 employees, OEM Solutions operates 13 facilities in the UK, US, Ireland, France and Malaysia."

The company said the acquisition will make it the largest orthopaedic contract manufacturer in the world with 18 facilities located in five countries on three continents.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Genstar Capital principal Rob Rutledge said: "Original equipment manufacturers are moving more of their manufacturing out to contract manufacturers that can handle the volume and provide the systems support."

"This merger provides a contract manufacturing platform paramount to anything else in the orthopaedic industry."

In the transaction, UBS Investment Bank served as exclusive financial advisor, while Weil, Gotshal & Manges acted as legal advisor for Tecomet.

Tecomet produces orthopaedic implants, precision surgical instruments, trauma plates and photochemical etched products for medical device customers.

The company uses prototyping and engineering capabilities to produce highly complex products that offer new solutions for demanding products and applications.